Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …

Background Enhanced recovery after surgery (ERAS) pathways are now implemented
worldwide with strong evidence that adhesion to such protocol reduces medical …

PURPOSE To conduct an update of the ASCO venous thromboembolism (VTE) guideline.
METHODS After publication of potentially practice-changing clinical trials, identified through …

PURPOSE To provide updated recommendations about prophylaxis and treatment of
venous thromboembolism (VTE) in patients with cancer. METHODS PubMed and the …

Purpose Venous thromboembolism (VTE) is common in patients with cancer. Long-term
daily subcutaneous low molecular weight heparin has been standard treatment for such …

Background This is the first updated Enhanced Recovery After Surgery (ERAS) Society
guideline presenting a consensus for optimal perioperative care in gynecologic/oncology …

Background Low-molecular-weight heparin is the standard treatment for cancer-associated
venous thromboembolism. The role of treatment with direct oral anticoagulant agents is …

Purpose To increase awareness, outline strategies, and offer guidance on the
recommended management of immune-related adverse events in patients treated with …

Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After
Surgery (ERAS®) Society recommendations — Part II - ScienceDirect Skip to main contentSkip …

Venous thromboembolism (VTE) is a significant health problem in the general population
but especially in cancer patients. In this review, we discuss the epidemiology and burden of …